Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use: A 12-Week, Open-Label, Post-Marketing Surveillance Study

Author: Michel Martin C.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.31, Iss.6, 2008-01, pp. : 505-514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content